Natera, Inc.
NTRA
16 insider filings · Latest: Mar 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Mar 18 1:05 AM | Rowan E ChapmanDirector | Sale | 122 | $191.38 | $23.3K | 5,752(D) | View → |
| Mar 16, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Sale | 50,000 | $196.28 | $9.8M | 2,310,772(D) | View → |
| Mar 13, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Sale | 75,000 | $189.01 | $14.2M | 2,310,772(D) | View → |
| Mar 12, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Sale | 75,000 | $190.59 | $14.3M | 2,310,772(D) | View → |
| Mar 10, 2026 | Mar 12 1:35 AM | Michael Burkes BrophyCHIEF FINANCIAL OFFICER | Sale | 785 | $204.13 | $160.2K | 63,354(D) | View → |
| Mar 10, 2026 | Mar 12 1:35 AM | Steven Leonard ChapmanDirector, CEO AND PRESIDENT | Sale | 5,623 | $204.13 | $1.1M | 156,607(D) | View → |
| Mar 10, 2026 | Mar 12 1:05 AM | Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER | Sale | 1,745 | $204.13 | $356.2K | 233,285(D) | View → |
| Mar 10, 2026 | Mar 12 1:05 AM | Jonathan SheenaDirector, Other | Sale | 127 | $204.13 | $25.9K | 262,325(D) | View → |
| Mar 10, 2026 | Mar 12 1:05 AM | John FeskoPRESIDENT, CHIEF BUS. OFFICER | Sale | 707 | $204.13 | $144.3K | 189,199(D) | View → |
| Mar 10, 2026 | Mar 11 10:05 PM | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | Sale | 915 | $204.13 | $186.8K | 150,882(D) | View → |
| Mar 6, 2026 | Mar 11 1:05 AM | Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER | Sale | 8,398 | $196.08 | $1.6M | 233,285(D) | View → |
| Mar 2, 2026 | Mar 4 2:05 AM | Jonathan SheenaDirector, Other | Sale | 3,070 | $200.23 | $614.7K | 262,194(D) | View → |
| Mar 2, 2026 | Mar 4 2:05 AM | Steven Leonard ChapmanDirector, CEO AND PRESIDENT | Sale | 3,950 | $200.02 | $790.1K | 156,607(D) | View → |
| Mar 2, 2026 | Mar 4 2:05 AM | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | Sale | 3,000 | $199.85 | $599.5K | 150,023(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Option Exercise | 50,000 | $9.59 | 100,000(D) | View → |
| Mar 13, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Option Exercise | 75,000 | $9.59 | 150,000(D) | View → |
| Mar 12, 2026 | Mar 17 1:05 AM | Matthew RabinowitzDirector, EXECUTIVE CHAIRMAN | Option Exercise | 75,000 | $9.59 | 225,000(D) | View → |
| Mar 6, 2026 | Mar 11 1:05 AM | Daniel RabinowitzSEC. AND CHIEF LEGAL OFFICER | Option Exercise | 5,598 | $19.68 | 0(D) | View → |
| Mar 2, 2026 | Mar 4 2:05 AM | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | Option Exercise | 5,125 | $9.59 | 0(D) | View → |